Board of directors

Our Board of directors is responsible for the guidance, risk management and strategic direction of Hudson Institute.

Dr Bob Edgar AM, member of the Board of Directors at Hudson Institute

Dr Robert (Bob) Edgar AM

BEcon (Hons), PhD (Ohio State)

Dr Edgar has extensive experience in financial services, including 25 years at ANZ Bank where he retired as deputy chief executive officer.
Special responsibilities: board chair

Professor Christina Mitchell AO, member of the Board of Directors at Hudson Institute

Professor Christina Mitchell AO

MBBS, PhD, FRACP, FAHMS

Professor Mitchell is Dean, Faculty of Medicine, Nursing and Health Sciences at Monash University, having trained as a physician scientist specialising in clinical haematology. She was the first woman to be appointed Dean of Medicine of a Go8 University in Australia. Her research group has focused on the molecular drivers of human cancer. Prof Mitchell is an inductee on the Victorian Honour Roll of Women and a recipient of the Lemberg Medal. She is an Order of Australia award recipient for distinguished service to medicine in the field of haematology, to medical education and research, and to academic leadership. Prof Mitchell is a member of the Australian Academy of Health and Medical Sciences. She is council chair, Monash Partners Academic Health Sciences Centre and is a director on the boards of Alfred Health and The Sylvia and Charles Viertel Charitable Foundation Medical Advisory Board.

Professor Warwick Anderson AM, member of the Board of Directors at Hudson Institute

Professor Warwick Anderson AO

PhD, FAAHMS, Hon LLD, DUniv, DHealth

Professor Anderson is an emeritus professor at Monash University, and Chair of Global Biodata Coalition. He was previously secretary-general of the international organisation Human Frontier Science Program, as well as CEO of the NHMRC and a member of numerous national and international medical research bodies. He has held academic and research positions at Monash University, Baker Medical Research Institute, University of Sydney and Harvard Medical School.

Mr Andrew Leyden, member of the Board of Directors at Hudson Institute

Mr Andrew Leyden

BComm

Mr Leyden is managing director and CEO of Lazard Australia Pty Ltd, an independent corporate advisory firm. He has worked in the investment banking industry in Australia for over 30 years and has experience across a range of industries, including healthcare, energy, infrastructure, resources and financial services.
Special responsibilities: chair, Investment Committee

Ms Zita Peach, member of the Board of Directors at Hudson Institute

Ms Zita Peach

BSc, FAICD, FAMI

Ms Peach is a non-executive director with experience on ASX listed, government and not-for-profit boards. She has also worked in senior leadership roles as executive vice-president and managing director of Fresenius Kabi, vice-president of Business Development at CSL Limited and Commercial Director at Merck Sharp Dohme. Ms Peach has extensive experience in commercialising technologies, licensing, mergers and acquisitions. She is a fellow of the Australian Institute of Company Directors and a fellow of the Australian Marketing Institute. She is also a director on the boards of Monash IVF Group Limited, Pacific Smiles Group Ltd (Chair), Icon Cancer Care (non-executive director) and Nucleus Network (non-executive director).
Special responsibilities: chair, Intellectual Property and Commercialisation Committee

Professor Kim Cornish, member of the Board of Directors at Hudson Institute

Professor Kim Cornish AM

BS (Hons), PhD (London)

Professor Cornish is director of the Turner Institute for Brain and Mental Health and a Sir John Monash distinguished professor. Prior to joining Monash University in 2009, she was a Canada Research Chair (Tier 1) at McGill University (Montréal, Canada). In 2017, Prof Cornish was elected Fellow of the Academy of the Social Sciences in Australia. Over her 30-year career, Prof Cornish has received over $17 million in competitive grant, fellowship and philanthropic funding. Her research has been lauded for advancing knowledge and developing new approaches to treating pervasive cognitive deficits in children with developmental disorders, e.g. autism and ADHD. Her work has been the catalyst for the development of novel interactive programs to help detect and train vulnerable cognition in early life, be delivered to scale, and personalised to each child’s strengths and challenges.

Mr Chris Dodd, member of the Board of Directors at Hudson Institute

Mr Chris Dodd

MBA, FCAANZ

Mr Dodd is a senior partner at PwC and has over 30 years of accounting and finance experience. He provides services to clients in the ASX100 across mining, infrastructure, technology and many other industries. He spent two years working in the UK and shorter stints in Asia and Africa. He is also a director on the boards of Peter MacCallum Cancer Foundation and Loreto Ministries.
Special responsibilities: chair, Finance and Audit Committee 

Mr George Ou

MBA, CPA

Mr Ou was appointed executive director of Financial Resources Management Division at Monash University in 2018 and leads a team responsible for developing and managing Monash’s budget and monitoring the university’s financial performance. He joined Monash University in 2001 and has held various middle and senior management roles within the Finance portfolio. He has extensive experience in financial management, is a certified practicing accountant with CPA Australia and holds an MBA from Monash University.
Special responsibilities: Finance and Audit Committee member

Professor the Hon. Jill Hennessy AO

Professor the Hon. Jill Hennessy

GAICD, BA, LLB, LLM

Professor Hennessy is a vice chancellor’s professorial fellow at Monash University and sits on many private sector and for-purpose boards as a non-executive director, chair and strategic advisor. Before entering parliament Prof Hennessy practised as a private sector solicitor and was a senior advisor to former Victorian premier Steve Bracks. She holds a Bachelor of Laws and Bachelor of Arts from Monash University as well as a Master of Public and International Law from the University of Melbourne. She is the ambassador for The McKinnon Prize in Political Leadership and chair of the Monash Women’s Health Alliance and Wellness Infrastructure.

Company secretary

Mr Rob Merriel, Company Secretary at Hudson Institute of Medical Research

Mr Rob Merriel

BA, Grad Dip (Psych), Grad Dip (Accounting), CPA

Mr Merriel is a certified practicing accountant (CPA) with over 40 years of experience working in medical research (Hudson Institute of Medical Research and Baker Institute), large public healthcare services (Melbourne Health and Southern Health) and commercial organisations (Pacific Dunlop and Deloitte Consulting). He has been a director of two Venture Capital Funds and a director and company secretary of several biotechnology focused medical research institute spin off companies. He is non-executive director of Invion Limited (ASX:IVX).
Special responsibilities: Finance and Audit Committee secretary, Investment Committee member, Intellectual Property and Commercialisation Committee secretary

Board committees

Finance and Audit Committee

This committee assists the board in internal control and compliance, accounting and financial reporting and risk management processes of Hudson Institute.
Members: Mr Chris Dodd (chair), Mr George Ou, Mr Rob Merriel (secretary), Professor Elizabeth Hartland, Mr Alan Lahiff (financial comptroller) and Sophianne Marinis (accountant)

Investment Committee

This committee advises the board and director on the effectiveness of investment policies and approves the engagement of investment managers and investment transactions.
Members: Mr Andrew Leyden (chair), Mr Rob Merriel and Mr Alan Lahiff (Secretary)

Intellectual Property and Commercialisation Committee

This committee advises the board and director on statutory requirements for corporate governance and commercialisation of Hudson Institute’s intellectual property and related issues.
Members: Ms Zita Peach (chair), Dr Andrew Gearing, Dr Alastair Hick, Dr Chris Smith, Dr Tony Eglezos, Mr Rob Merriel (secretary), Professor Elizabeth Hartland, Professor Claudia Nold, The Hon. Jill Hennessy AO – commenced Sept 2023, Ms Carmela Monger (Business Development Manager) and Dr Ryan Huang (Commercialisation Associate)